Table

Multidrug-Resistant Tuberculosis in Prison Inmates, Azerbaijan

Gaby E. Pfyffer*

, Anni Strässle*, Tamara van Gorkum†, Françoise Portaels‡, Leen Rigouts‡, Christine Mathieu§, Fuad Mirzoyev§, Hamidou Traore‡, and Jan D.A. van Embden†

Author affiliations: *University of Zurich, Zurich, Switzerland; †National Institute of Public Health and Environmental Protection, Research Laboratory for Infectious Diseases, Bilthoven, the Netherlands; ‡Institute of Tropical Medicine, Antwerp, Belgium; §International Committee of the Red Cross, Geneva, Switzerland

Main Article

Characteristics of the cohort of prison inmates with tuberculosis, Azerbaijan

Strain no.	Age of patient (years)	Body mass index	Patient group^a	Onset of symptoms	Previous treatment (before enrollment in ICRC program)^b
7933	25	18.2	A	Aug 1996	R,E,S
7887	40	--	A	Jan 1995	H,R,E,S
7909	40	16.1	A	Jun 1995	S (4 mo. in 1995) S (1 mo. in 1996)
7920	22	16.3	A	Mar 1995	H(?),R(?),S
5695	22	17.2	B	Feb 1996	S
5698	43	--	A	1976	R,E
7101	20	--	B	Jan 1996	S
5691	26	--	A	Feb 1995	S
7915	21	16.2	B	Mar 1996	None
7922	33	16.1	A	Spring 1996	H,R,E,S
5689	24	19.7	A	1993	H,R,E,S (1 to 2 mo.)
7924	40	17.4	B	Apr 1996	H,R,E,S
7934	36	--^c	A	Jul 1996	S
7908	32	16.1	B	Mar 1996	R,E,S
7930	21	16	B	Aug 1996	R,E,S
7935	23	17.3	B	Mar 1996	R
7925	22	19.3	A	Feb 1996	S (monotherapy initially); R,E,S (2 to 3 mo.)
7931	21	16	B	Jul 1996	R,S
7914	34	15.7	A	Nov 1995	R,E,S (not completed)
5713	25	15.6	B	Dec 1995	H,R,E,S
7910	32	17.5	A	Feb 1996	S,E (not completed)
7906	22	19.5	B	Aug 1996	R,S
5719	32	--	C	1991	H,R,E,S (9 mo. in 1991)
7923	34	13.8	B	Jan 1996	R,E,S
7899	33	15.8	A	Jan 1996	H (4 mo.), R (10 d), E (4 mo.), S,Z (4 mo.) (not completed)
5684	29	17.2	A	1993	H,R,E,S (in 1994) S (in 1995)
7900	?	20.2	A	Jul 1995	H,R,S (in 1995) S (in 1996)
5697	19	17.4	B	Mar 1996	none
5692	22	--	A	Feb 1995	H,R,E,S
7916	32	18.2	A	1994	H,R,E,S,K (several <3-mo.-intervals of treatment)
7932	22	18.1	C	Nov 1993	H,R,E,S,K (several intervals of treatment: 1 mo., 4 mo., 12 mo.)
5700	34	18	B	Feb 1996	none
5702	26	18.1	A	Sep 1995	S
5706	23	--	B	Feb 1996	S
5716	24	19	B	Feb 1996	R,S
7888	30	--	A	Oct 1994	H,R,E,K (<2 mo. in 1994) H,R (in 1995)
5705	27	--	B	Sep 1995	None
5693	26	17.2	B	Jan 1996	S
5722	26	17.1	B	Dec 1995	H,R,E,S,K
7895	19	18.5	B	Jun 1996	H,R,S
5724	37	17.3	B	Dec 1995	H,R,E,S
7886	46^c	--	A	Mar 1995	R,E,S (not completed)
7917	55	--	C	1987	R,E,S (11 mo.)
5718	20	17.6	B	Oct 1995	H,K
7889	?	--	A	?	?
7921	22	19.4	B	Jul 1996	S
7926	20	--^c	B	Aug 1996	none
7918	33	16.4	B	Jul 1996	H,R,E,S
7927	32	18.4	A	Mar 1996	H,E,S (not completed)
7904	21	16.8	B	May 1996	H,S
7929	47	26.3	A	May 1996	R,E,S (not completed)
7894	28	17.3	B	Apr 1996	None
7897	20	13.8	A	Jan 1996	R,E,S (not completed)
7905	26	18.6	B	Apr 1996	S
7907	19	14	B	Dec 1995	H,S
7902	25	19.2	A	1995	H,S (6 mo.) R,E, (7 d)
5686	29	--	A	May 1995	H,R,E,S (not completed)
5694	29	17.3	A	Jan 1995	H,S (1 mo. in 1995) E,S (1 mo. in 1996)
5726	44	16.9	A	?	H,R,E,S (3 to 4 mo. in 1991) H,R,E,S (in 1995)
7911	34	17.9	B	Mar 1995	R,E,S,K
5688	37	--	A	Sep 1994	R,E,S
5687	41	20.3	B	Feb 1996	E,S
5729	40	16.3	C	1994	R,S(3 mo. in 1994) S (in 1996)
7890	19	--	A	1994	H,E,S (3 mo. in 1994) R,E,S (in 1996)
5699	22	--	B	Mar 1996	H,S

^aGroup A = nonresponders; Group B = new cases (never treated or treated for <1 month); Group C = relapsed cases
^bH, isoniazid; R, rifampin; E, ethambutol; S, streptomycin; Z, pyrazinamide; K, kanamycin
^cPatient too weak to be weighed

Main Article

Page created: April 26, 2012

Page updated: April 26, 2012

Page reviewed: April 26, 2012

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.